Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Lorenzo Falchi

A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy

scientific article

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.

scientific article

An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma

scientific article published on 23 May 2018

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

scientific article published on 09 December 2011

Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?

scientific article published on 16 December 2016

Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era.

scientific article

BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia

scientific article

Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial

scientific article published on 21 December 2017

Bullet 'manicure': does lead prevent hydroxyurea-induced cutaneous toxicity?

scientific article published on May 2014

Chronic lymphocytic leukemia in African Americans

scientific article published on 09 July 2012

Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center

scientific article

Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia

scientific article

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study

scientific article published on 07 July 2009

ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant

scientific article published on 23 May 2014

Eosinophilia in Hematologic Disorders

scientific article

Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes

scientific article published on 30 July 2010

High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy

scientific article published on 30 November 2016

High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience

scientific article published on 18 April 2012

Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based Strategies.

scientific article published on 18 August 2017

Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

scientific article published on 23 February 2016

Kit Mutations: New Insights and Diagnostic Value

scientific article published on 09 June 2018

Maesopsin 4-O-β-D-Glucoside, a Natural Compound Isolated from the Leaves ofArtocarpus tonkinensis, Inhibits Proliferation and Up-Regulates HMOX1, SRXN1 and BCAS3 in Acute Myeloid Leukemia

scientific article published on June 1, 2011

New Therapeutic Approaches in Polycythemia Vera

scientific article (publication date: June 2015)

Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics

scientific article published on 05 January 2016

Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies

scientific article published on 18 April 2019

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

scientific article published on 01 October 2019

Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy

scientific article published on 21 August 2009

Severe mechanical hemolysis in a patient with thalassemia minor who had undergone inappropriate splenectomy

scientific article published on 20 May 2016

Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors

scientific article published on 12 September 2013

Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans

scientific article published on June 28, 2012

Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution

scientific article published in June 2010

The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy - the MD Anderson Cancer Center experience

scientific article published on 30 March 2015

The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

article

The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.

scientific article

The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review.

scientific article published on 14 August 2017

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's Lymphomas

scientific article published on 14 June 2012

Tyrosine Kinase Inhibitors

scientific article published on 01 August 2010